Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants.
Seki Y, Yoshihara Y, Nojima K, Momose H, Fukushi S, Moriyama S, Wagatsuma A, Numata N, Sasaki K, Kuzuoka T, Yato Y, Takahashi Y, Maeda K, Suzuki T, Mizukami T, Hamaguchi I.
Seki Y, et al. Among authors: yoshihara y.
Med. 2022 Jun 10;3(6):406-421.e4. doi: 10.1016/j.medj.2022.04.013. Epub 2022 Apr 26.
Med. 2022.
PMID: 35815933
Free PMC article.